Buteyko versus Pilates breathing paired with McKenzie neck exercises for breathing and posture in people with asthma

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This interventional, parallel-group program enrolls adults (18–40) with well-controlled asthma and forward head posture and assigns them to one of two 4-week combined exercise regimens. Group A performs McKenzie neck exercises plus Pilates-based breathing, while Group B performs McKenzie neck exercises plus Buteyko breathing. Outcomes measured before and after the intervention include spirometry, chest expansion, postural measures, and quality-of-life questionnaires. The protocol excludes people with severe or unstable cardiopulmonary disease, recent thoracic surgery or trauma, active infections, pregnancy, or other contraindications to exercise.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Age group 18-40years
* Both males and females
* Individuals clinically diagnosed with asthma that is well controlled (Level 1 and Level 2) with FHP
* Not participated in any structured exercise regime for improving lung function during the past 6 months.
* Individuals well tolerated with a current exercise plan of combination exercises. (Buteyko breathing/Pilate breathing and McKenzie neck exercises

Exclusion Criteria:

* -Level 3 and 4 asthma or status asthmatics.
* Any congenital deformity of the chest wall
* Any active infections like fever, TB
* Those with any contraindication to exercise testing or training.
* Recent history of any chest wall trauma
* Any abdominal or cardio thoracic surgery
* Any psychiatric illness
* Unstable Cardiopulmonary disease i.e. unstable angina, heart failure, recent MI.
* Unstable hemodynamic parameters (arterial pressure \>140mmhg systolic and \>90mmhg for diastolic
* Pregnancy
* Previous or parallel participation in interventional programs.

Where it's running

• Foundation University College of Physical Therapy, Islamabad, 44000
  Islamabad, Pakistan Recruiting

Study contacts

• Study coordinator: Arzoo Bashir Awan, DPT
• Email: arzoobashir66@gmail.com
• Phone: 03215770272

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Chronic Respiratory Disease Participant Engagement

  This study tests whether adults with long-term lung conditions can get comfortable with a clinical trials unit and research team before joining future trials.

  Recruiting Richmond Pharmacology Limited · London · NCT07924462

• HB0056 in adults with moderate to severe asthma

  This study tests HB0056 versus a placebo to see if it helps adults with moderate to severe asthma reduce rescue inhaler use and improve symptoms.

  Recruiting at 2 sites Phase 1/2 Shanghai Huaota Biopharmaceutical Co., Ltd. · Beijing and 1 other locations · NCT07899996

• Tilrekimig (PF-07275315) for Severe Asthma: Aimed at Adults with Frequent Exacerbations

  This study tests whether tilrekimig helps people with severe asthma who have had multiple flare-ups in the past year, by comparing it to a placebo given every four weeks.

  Recruiting at 4 sites Phase 3 Pfizer · River Forest, Illinois and 11 other locations · NCT07869043

• Inhaled CHF10136 safety and pharmacokinetics in healthy adults and adults with asthma

  This first-in-human study tests inhaled CHF10136 to see if it is safe and well tolerated, how it behaves in the body, and how it affects adults with asthma compared with placebo.

  Recruiting Phase 1 Chiesi Farmaceutici S.p.A. · Leeds and 2 other locations · NCT07851623

• Biologics for Type 2 Inflammation in Asthma and COPD in Real World

  This real-world study tests whether six biologic drugs can reduce flare-ups and improve symptoms in adults with asthma or COPD treated in routine care in China.

  Recruiting Shanghai Pulmonary Hospital, Shanghai, China · Shanghai, Shanghai Municipality · NCT07823842

• GSK5784283 vs placebo in uncontrolled asthma (PERSIST ASTHMA-2)

  A new medicine called GSK5784283 is being tested to see if it lowers asthma flare-ups better than a placebo in people with uncontrolled asthma.

  Recruiting at 7 sites Phase 3 GlaxoSmithKline · San Diego, California and 6 other locations · NCT07782996

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.